A new study reveals how Epstein-Barr virus may provoke immune cells to attack the brain, offering fresh hope for treating ...

About 1 million people are living with multiple sclerosis in the U.S., and about 10% of those have PPMS, making it the least common form of the disease.

New research suggests that Epstein-Barr virus may actively provoke the immune system in people with multiple sclerosis. Scientists found large buildups of virus-targeting immune cells in the nervous ...

Roche has shared the numbers behind its phase 3 win in primary progressive multiple sclerosis (PPMS), linking its BTK ...

Signs of multiple sclerosis may surface years before diagnosis, as patients use healthcare more often for early symptoms.

New research shows early Multiple Sclerosis brain damage is dynamic and reversible. Myelin swellings can shrink and disappear ...

Cerebrospinal fluid (CSF)-based molecular tests can reliably distinguish multiple sclerosis (MS) from other neurological ...

Music activates multiple parts of the brain. For people with MS, a choir is exploring what singing together can offer.

Study shows certain CD8+ immune cells are far more active in the nervous system of people with multiple sclerosis. Some ...

Unique opportunity for the multiple sclerosis (MS) community to inform new approaches to treating MS WASHINGTON, Oct. 22, 2025 /PRNewswire/ -- The National Multiple Sclerosis Society (Society) ...

With ads everywhere for pro- or pre-biotic foods and supplements, most people are familiar with the gut microbiome-the trillions of bacteria, fungi, and viruses that colonize our digestive tract-and ...

Fenebrutinib numerically reduced the risk of disability progression by 12% compared to OCREVUS as early as 24 weeks; additional analysis showed potential benefit in upper limb function Fenebrutinib ...